ORIGIO A/S

CVR10975077

Stamdata

Navn
ORIGIO A/S
Adresse
Lautrupvang 2 1 th, 2750, Ballerup
Stiftelsesdato
1. jul. 1987
Antal
83 / 82
Lokationer (P-enheder)
1Se lokationer
Hjemmeside
https://www.coopersurgical.com/brand/origio/
Branche
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Hold øje med ORIGIO A/S

Få en email, når vi registrerer ændringer i regnskaber, ejerskab eller ledelse. Så slipper du for selv at tjekke virksomheden.
Gratis konto

Beskrivelse

ORIGIO has been part of the CooperSurgical Companies since 2012. CooperSurgical Fertility Solutions is the global leader in IVF (In Vitro Fertilisering) and reproductive genetics, providing innovative products and services for every step in the ART journey (Assisted Reproductive Technology). Our company vision is a world with healthy women, babies and families. ORIGIO A/S was established in 1987 and has been a global leader in delivering innovative ART solutions. Combining the scientific knowledge with the CooperSurgical fertility companies ORIGIO, Research Instrument, Safe Obstetrics Systems and Invitro offer a broad range of trusted systems of consumables, equipment, and technologies for a complete IVF process. In 2016 Reprogenetics, Recombine and Genesis Genetics joined the CooperSurgical family, and represented the pioneers and global leaders of comprehensive reproductive genetic testing. As CooperGenomicsSM, they are the premier provider of genetic testing for every step of the family planning journey. Our combined product range includes pipettes, media and andrology products, and dedicated ART equipment, as well as state-of-the art electronic witnessing system. Our broad portfolio of products and services are being developed jointly in partnerships with experts and clinics across the globe to improve the ART solutions. Our industry-leading ART development program includes 7 Centers of Excellence around the world as well as collaboration with our external partners' training facilities, such as the Centre of Reproductive Medicine at the Vrije Universiteit Brussel in Brussels. We offer a wide range of courses and workshops for embryologists, gynecologists, lab managers and R&D scientists at every level of experience, with hands-on expert training in breakthrough technologies and next-generation techniques. Our team of experienced embryologists also assists customers with the establishment of clinics (tum-key projects), laboratory design, and clinic audits to optimize lab performance. In addition, they give lectures, run seminars and workshops, and support the research and development of new products. ORIGIO will continue its focus to further grow and strengthening it's strong position in offering best in class products, driving and evolving innovation in line with customer needs. The collaboration within the CooperSurgical Companies and trusted partnerships open doors to extensive possibilities for the future.

Økonomi

Selskabsregnskab
Regnskabsperiode
2024/251. nov. 2024 - 31. okt. 2025kr.
Omsætning
760.810.000
Bruttofortjeneste
157.449.000
Driftsresultat
32.868.000
Resultat før skat
9.305.000
Årets resultat
4.884.000
Samlede aktiver
443.349.000
Egenkapital
171.727.000
Gns. ansatte
107
2017–2025

Lås regnskabshistorikken op

Datapublica Risk Score

Låst
Vurderer risikoen for økonomiske problemer ud fra virksomhedens regnskaber, historik og relationer.
Virksomhedens score
0 · Lav100 · Høj

Det indgår i vurderingen

  • Økonomi

  • Regnskaber og historik

  • Ejere og ledelse

  • Virksomhed og relationer

Standard: Score og risikoniveauPro: Også detaljeret forklaring af faktorerne

Kontakt

Fra cvr.dk

Virksomhed
8082****Vis hele
sa***@coopersurgical.comVis hele

Gazelle

Henter gazelle-status…

Børsen Gazelle er Dagbladet Børsens kåring. Datapublica er ikke tilknyttet Børsen. Beregnede statusser er Datapublicas egen analyse af offentlige CVR-regnskabsdata.

Ledelse og roller

Ingen aktuelle ledelses- eller rolleoplysninger tilgængelige

Revisor

KPMGStatsautoriseret RevisionspartnerselskabRevisorIlhan DoganRolleState Authorised Public AccountantFra18. maj 2026

Legale ejere

Udenlandsk juridisk enhed

Ejerandel100 %Stemmeandel100 %Fra29. jan. 2016

Dattervirksomheder

Ejerandel100 %Stemmeandel100 %Fra17. aug. 1994

Ultimative ejere

🇬🇧RESEARCH INSTRUMENTS LIMITED
Ejerskab gennem
Direkte
100 %